Oxytocin

What Oxytocin is, structurally

Oxytocin is a nonapeptide with a C-terminal amide rather than a free acid, and it is partly cyclic.

The formula reconciles exactly. Twelve nitrogens comes from nine backbone amides, one each for the glutamine and asparagine side chains, and one for the C-terminal amide. No basic residue is present, which is why the count stops there.

The two sulfurs are the cysteines at positions one and six, and they are joined: the deposited structure for this CAS shows an explicit disulfide, so this is confirmed rather than inferred. That bridge closes the first six residues into a ring, leaving proline, leucine and glycine as a short acyclic tail. The molecule is a cyclic hexapeptide with a tripeptide extension, the ring constrained in a way the tail is not.

Charge is unusual for this length: there is essentially none. No basic residue, no acidic side chain, an amidated C-terminus, and the N-terminal amine as the only ionisable group in the molecule.

Two residues carry amide side chains, glutamine at four and asparagine at five, adjacent to each other inside the ring. Both deamidate, asparagine faster. The tyrosine at two is the only aromatic residue and the only useful chromophore. There is no methionine and no tryptophan.

The peptide is water soluble, though no quantitative figure is quoted here.

Reconstitution and handling

Sterile water is the default solvent, and with no metal centre present PBS or an appropriate assay buffer are equally suitable. Add diluent down the inside wall of the vial, swirl gently, and let the solution clarify.

Keep reducing agents out. Dithiothreitol, TCEP and excess free thiol all open the disulfide, converting the molecule into a linear nonapeptide, a different substance rather than a damaged one. Reducing agents are a routine default in peptide buffers, which is what makes this worth checking.

Prepare near neutral pH and use solutions promptly. Both liabilities on this molecule, deamidation and disulfide exchange, accelerate under alkaline conditions, so pH is doing double duty here.

Adsorption is worth allowing for at low concentration, with low-protein-binding tubes reducing measured loss. A near-neutral molecule has more affinity for surfaces than a strongly charged peptide would.

This is laboratory preparation chemistry, not dosing, administration, or protocol guidance of any kind.

Storage and stability

Store the lyophilized powder at -20 degrees C, sealed, desiccated and protected from light, and let a cold vial warm before opening. Reconstituted, hold at 2 to 8 degrees C, or aliquot and freeze rather than thawing repeatedly.

Two independent liabilities apply, and they fail differently.

The adjacent glutamine and asparagine deamidate, turning a neutral side chain acidic and adding roughly one mass unit each, asparagine faster. The reaction needs water, so the solid is largely protected while solutions are not, and warmth and alkaline pH accelerate it.

The disulfide is stable to air but not to reduction, and at alkaline pH it can exchange. With a single bridge in the molecule, exchange between molecules produces dimers and higher aggregates rather than a rearranged monomer.

Near-neutral, cold, promptly used solutions address both. There is no oxidation route at sulfur to worry about separately, because both sulfurs are already committed to the bridge.

These are storage conditions for the material, not dosing or administration guidance.

How Oxytocin is tested

Reversed-phase HPLC establishes chromatographic purity as area percent. The single tyrosine gives modest absorbance near 280 nm, but with only one aromatic residue in nine, the low-UV amide measurement near 214 nm is the more reliable channel.

Area percent is a chromatographic measure rather than peptide content by weight. Solid-phase synthesis delivers a salt, commonly trifluoroacetate or acetate, though with only one ionisable group in the molecule the counter-ion load is lower here than on a peptide carrying several basic residues.

Mass spectrometry confirms identity and separates the two liabilities by their signatures. Reduction adds two mass units, so running with and without a reducing agent confirms the bridge: the mass should rise by exactly two. A disulfide-linked dimer appears near 2014. Deamidation adds about one unit per event, and with two susceptible residues both plus-one and plus-two are possible. On a molecule of 1007 those sit close to the parent's isotope envelope, so chromatography is often the better indicator, the deamidated forms being more acidic.

These describe general methodology, not a claim about any particular batch.

Handling FAQ

Can a reducing agent be added to the buffer? No. The disulfide between positions one and six is what makes this molecule cyclic, and opening it produces a linear nonapeptide, a different compound rather than a degraded one. Since reducing agents are a common default addition to peptide buffers, this is worth checking explicitly.

Why does pH matter for both liabilities at once? Because alkaline conditions accelerate deamidation of the glutamine and asparagine and also promote disulfide exchange. Working near neutral suppresses both, which is convenient, since the two routes are otherwise unrelated.

Full specifications for Oxytocin.